Joel Ackerman, Chief Executive Officer at CHAMPIONS ONCOLOGY, INC. (CSBR), bought 33 shares at $1.65 ($54) on 2016-09-23, disclosed to the SEC on 2016-09-26.
Open-market purchase of $54 CSBR by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| DVA | SELL | 2021-08-06 | $9.9M | — | Filing → |
| CSBR | SELL | 2018-10-03 | $767K | — | Filing → |
| CSBR | BUY | 2016-10-20 | $5K | — | Filing → |